Last reviewed · How we verify

NCT06756854

Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.

Completed Phase 3 Last updated 3 January 2025
What this trial tests

Phase 3 trial testing Biologic Agent: injectable platelet rich fibrin. in Periodontal Diseases in 7 participants. Completed in 15 June 2024.

Timeline
12 September 2023
Primary endpoint
14 May 2024
15 June 2024

Quick facts

Lead sponsorFaculty of Dental Medicine for Girls
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment7
Start date12 September 2023
Primary completion14 May 2024
Estimated completion15 June 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Dental Medicine for Girls — full company profile →

Who can join

Adults 18 to 40, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Management of thin gingival phenotype using non-surgical methods (injection of liquid platelet rich fibrin and exposure to low level laser therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Faculty of Dental Medicine for Girls trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06756854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing